Patents by Inventor Talbir Austin

Talbir Austin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CO-CRYSTAL OR SALT
    Publication number: 20230279032
    Abstract: The invention relates to a co-crystal or salt comprising psilocybin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-related disorders and stimulant-related disorders in a patient. A kit comprising the co-crystal or salt is also described.
    Type: Application
    Filed: March 3, 2023
    Publication date: September 7, 2023
    Inventors: JOHN KNIGHT, TALBIR AUSTIN
  • CO-CRYSTAL OR SALT
    Publication number: 20230202978
    Abstract: The invention relates to a co-crystal or salt comprising psilocin and a co-former. The co-crystal or salt is useful in methods of treating or preventing a disease or condition selected from depression, anxiety, death anxiety, demoralization, adjustment disorders, hopelessness, suicidal ideation, desire for hastened death, cocaine-related disorders, opioid-related disorders and stimulant-related disorders in a patient. A kit comprising the co-crystal or salt is also described.
    Type: Application
    Filed: March 3, 2023
    Publication date: June 29, 2023
    Inventors: John Knight, Talbir Austin
  • NOVEL PIPERIDINE DERIVATIVES
    Publication number: 20130023562
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 27, 2012
    Publication date: January 24, 2013
    Applicant: ASTRAZENECA AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Piperidine derivatives
    Patent number: 8314127
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Grant
    Filed: July 19, 2006
    Date of Patent: November 20, 2012
    Assignee: Astrazeneca AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe
  • Novel Piperidine Derivatives
    Publication number: 20080207688
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a chemokine (such as CCR3) mediated disease state.
    Type: Application
    Filed: July 19, 2006
    Publication date: August 28, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Talbir Austin, David O'Sullivan, Matthew Perry, Brian Springthorpe